Driehaus Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.9M | Buy |
757,710
+522,637
| +222% | +$28.9M | 0.34% | 99 |
|
|
2025
Q1 | $11.4M | Sell |
235,073
-104,625
| -31% | -$5.06M | 0.11% | 227 |
|
|
2024
Q4 | $13.1M | Sell |
339,698
-105,654
| -24% | -$4.08M | 0.11% | 217 |
|
|
2024
Q3 | $20M | Sell |
445,352
-111,483
| -20% | -$5.02M | 0.17% | 171 |
|
|
2024
Q2 | $19.3M | Sell |
556,835
-3,695
| -0.7% | -$128K | 0.19% | 149 |
|
|
2024
Q1 | $16.2M | Buy |
560,530
+361,841
| +182% | +$10.5M | 0.16% | 187 |
|
|
2023
Q4 | $4.56M | Buy |
+198,689
| New | +$4.56M | 0.05% | 270 |
|